Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Are specialty drug prices destroying insurers and hurting consumers?: a number of efforts are under way to reduce price pressure.
Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease.
The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis.
Peptidylarginine deiminase and protein citrullination in prion diseases: Strong evidence of neurodegeneration.
Helicobacter pylori serology in autoimmune diseases - fact or fiction?
Quantitative MRI Analysis of the Brain after Twenty-Two Years of Neuromyelitis Optica Indicates Focal Tissue Damage.
Early versus delayed treatment with laquinimod demonstrated significant reduction in risk of disability progression – Results of three-year ALLEGRO study in relapsing-remitting multiple sclerosis
miR-17-92 cluster targets Phosphatase and Tensin Homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation.
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).
Abnormal control of orbicularis oculi reflex excitability in multiple sclerosis.
Multiple sclerosis in Syria.
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial.
Expectations of multiple sclerosis patients and their families: a qualitative study in iran.
Functional plasticity of the visual system in multiple sclerosis.
TNF-alpha Production by Peripheral Blood Monocytes in Multiple Sclerosis Patients and Healthy Controls.
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.
Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis.
Drug expenditure of high-cost patients and their characteristics in Finland.
Ginkgo biloba does not improve cognitive function in MS: A randomized placebo-controlled trial.
Mechanisms and Pharmacology of Neuropathic Pain in Multiple Sclerosis.
Vitamin D and multiple sclerosis.
Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease.
Steroid-responsive hearing impairment in NMO-IgG/aquaporin-4-antibody-positive neuromyelitis optica.
Neuromyelitis optica.
MR imaging and cognitive correlates of relapsing-remitting multiple sclerosis patients with cerebellar symptoms.
Pages
« first
‹ previous
…
325
326
327
328
329
330
331
332
333
…
next ›
last »